ID

22263

Descripción

Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00585416

Link

https://clinicaltrials.gov/show/NCT00585416

Palabras clave

Versiones (1)
  1. 27/5/17 27/5/17 -
Subido en

27 de mayo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00585416

Inglés

Eligibility Prostate Cancer NCT00585416

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
metastatic hormone refractory prostate cancer.
Descripción

metastatic hormone refractory prostate cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0936223
UMLS CUI [1,2]
C1328504
eastern cooperative oncology group (ecog) performance status of 0-1.
Descripción

ecog

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
testosterone <50ng/dl. patients must continue primary androgen deprivation with an lhrh analogue if they have not undergone orchiectomy.
Descripción

testosterone, androgen deprivation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0039601
UMLS CUI [2]
C0279492
progressive disease after androgen deprivation.
Descripción

disease progression after androgen deprivation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1328504
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients whose clinical condition would make chemotherapy clearly indicated.
Descripción

chemotherapy indicated by patient condition

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1444656
UMLS CUI [1,3]
C0683521
patients who have received systemic chemotherapy for the treatment of metastatic disease.
Descripción

systemic chemotherapy for metastatic disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1883256
UMLS CUI [1,2]
C0027627
peripheral neuropathy > grade 1
Descripción

peripheral neuropathy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0031117
prior anti-angiogenic therapy, including thalidomide.
Descripción

anti-angiogenic therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0596087
patients with inadequate recovery from any prior surgical procedure, or patients having undergone any major surgical procedure or radiation within 4 weeks prior to study entry.
Descripción

surgery recovery, prior major surgery or radiation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C2004454
UMLS CUI [2]
C0679637
UMLS CUI [3]
C1522449
patients who have received radiopharmaceuticals (strontium, samarium) within 8 weeks prior to enrollment.
Descripción

radiopharmaceuticals

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0182638
patients with known brain metastases or history of brain metastases.
Descripción

brain metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0220650
history of stroke within 6 months of treatment or other significant neurological limitations.
Descripción

surgery recovery, neurological limitations

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0027765
patients who have received more than 2 prior investigational treatments.
Descripción

investigational treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0949266
uncontrolled intercurrent illness
Descripción

comorbidities

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
patients with a history of a myocardial infarction within the prior 6 months or, hospitalizations for decompensated congestive heart failure within the prior 6 months, or history of significant / symptomatic cardiac arrhythmias
Descripción

myocardial infarction, hospitalizations for congestive heart failure, cardiac arrhythmias

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2,1]
C0018802
UMLS CUI [2,2]
C0019993
UMLS CUI [3]
C0003811
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT00585416

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
metastatic hormone refractory prostate cancer
Item
metastatic hormone refractory prostate cancer.
boolean
C0936223 (UMLS CUI [1,1])
C1328504 (UMLS CUI [1,2])
ecog
Item
eastern cooperative oncology group (ecog) performance status of 0-1.
boolean
C1520224 (UMLS CUI [1])
testosterone, androgen deprivation
Item
testosterone <50ng/dl. patients must continue primary androgen deprivation with an lhrh analogue if they have not undergone orchiectomy.
boolean
C0039601 (UMLS CUI [1])
C0279492 (UMLS CUI [2])
disease progression after androgen deprivation
Item
progressive disease after androgen deprivation.
boolean
C1328504 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
chemotherapy indicated by patient condition
Item
patients whose clinical condition would make chemotherapy clearly indicated.
boolean
C0392920 (UMLS CUI [1,1])
C1444656 (UMLS CUI [1,2])
C0683521 (UMLS CUI [1,3])
systemic chemotherapy for metastatic disease
Item
patients who have received systemic chemotherapy for the treatment of metastatic disease.
boolean
C1883256 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
peripheral neuropathy
Item
peripheral neuropathy > grade 1
boolean
C0031117 (UMLS CUI [1])
anti-angiogenic therapy
Item
prior anti-angiogenic therapy, including thalidomide.
boolean
C0596087 (UMLS CUI [1])
surgery recovery, prior major surgery or radiation
Item
patients with inadequate recovery from any prior surgical procedure, or patients having undergone any major surgical procedure or radiation within 4 weeks prior to study entry.
boolean
C0543467 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C0679637 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
radiopharmaceuticals
Item
patients who have received radiopharmaceuticals (strontium, samarium) within 8 weeks prior to enrollment.
boolean
C0182638 (UMLS CUI [1])
brain metastasis
Item
patients with known brain metastases or history of brain metastases.
boolean
C0220650 (UMLS CUI [1])
surgery recovery, neurological limitations
Item
history of stroke within 6 months of treatment or other significant neurological limitations.
boolean
C0038454 (UMLS CUI [1])
C0027765 (UMLS CUI [2])
investigational treatment
Item
patients who have received more than 2 prior investigational treatments.
boolean
C0949266 (UMLS CUI [1])
comorbidities
Item
uncontrolled intercurrent illness
boolean
C0009488 (UMLS CUI [1])
myocardial infarction, hospitalizations for congestive heart failure, cardiac arrhythmias
Item
patients with a history of a myocardial infarction within the prior 6 months or, hospitalizations for decompensated congestive heart failure within the prior 6 months, or history of significant / symptomatic cardiac arrhythmias
boolean
C0027051 (UMLS CUI [1])
C0018802 (UMLS CUI [2,1])
C0019993 (UMLS CUI [2,2])
C0003811 (UMLS CUI [3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial